The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’ - Edward Fanelli, 57, shared his regrets about taking Ozempic after he was diagnosed ...

From the commentary, "Congress must ultimately decide whether to pass legislation to lower drug prices. If they do, lawsuits ...

Jamie Dimon's Would-Be Successors Audition for the Top Job at JPMorgan Investors will gather in midtown Manhattan to see who might become the bank's next CEO. Trump Attacks Walmart for Tariff-Related ...

Is there anyone who thinks prescription drug prices in America are about right? President Trump has elevated an issue Democrats have been jawboning about for years. On Monday the president issued ...

The president's executive order will get blocked in courts, but Sen. Bernie Sanders is offering a legislative path to ...

Pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down ...

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...